Log In

Forgot Password?
Create New Account

Loading... please wait

Abstract Details

Clinical Characteristics of Contactin-1 IgG-associated Neuro-renal Syndrome
Neuromuscular and Clinical Neurophysiology (EMG)
S15 - Autoimmune Neuromuscular Diseases: New Observations and Therapeutic Approaches (1:36 PM-1:48 PM)
004

Only a few cases of contactin-1 IgG autoimmune nodopathy and concurrent nephrotic syndrome have been reported.

To describe the presentation of renal dysfunction and peripheral neuropathy associated with contactin-1 IgG seropositivity.

We retrospectively reviewed contactin-1 IgG-seropositive cases evaluated at Mayo clinic for neuropathy and/or renal dysfunction.

Of ten contactin-1 IgG seropositive cases identified, six had neuro-renal syndrome (polyradiculoneuropathy and renal involvement).  Four of six were males, and median age was 68 years (range 33-75). All patients were diagnosed with neuropathy prior to detection of renal dysfunction. Neuropathy symptom onset to nadir was 5 months (range 1-9 months). Four patients were monophasic while two had a relapsing course. Three patients had sensory-predominant presentations, while three had progressive asymmetric quadriparesis due to severe polyradiculoneuropathy. Sensory ataxia and pseudoathetosis were present in all but one case, and four patients required a wheelchair at disease nadir. Renal presentation was nephrotic syndrome (proteinuria n=5; hypoalbuminemia n=5; edema n=3; hypercholesterolemia/hypertriglyceridemia n=5), while creatinine was normal (n=4) or only mildly elevated (n=2). Renal biopsies performed in 4 cases showed membranous nephropathy (n=4) with immunofluorescence showing prominent IgG glomerular capillary wall staining, mainly of the IgG4 subclass (n=3). Mass spectrometry of immune complexes recovered from biopsy tissue of a patient revealed contactin-1. Nephropathy worsening was concurrent with neuropathy relapses in all cases; however, one patient had an isolated renal relapse 8 years later. Five patients demonstrated neurologic stabilization or improvement following immunotherapy, but two patients remained wheelchair bound (median follow-up time 19 months). Renal outcomes including proteinuria and hypoalbuminemia improved/stabilized in three patients treated with rituximab.

Renal dysfunction is common among patients with contactin-1 IgG associated autoimmune nodopathy.  These patients often have evidence of proteinuria, but creatine levels are usually normal. Similar to neuropathy, renal dysfunction also responds favorably to B-cell depleting therapies.

Authors/Disclosures
Grace Swart, MD
PRESENTER
Dr. Swart has nothing to disclose.
Jaclyn E. Jacobi, MD Dr. Jacobi has nothing to disclose.
Surendra Dasari No disclosure on file
Christopher J. Klein, MD, FAAN (Mayo Clinic) Dr. Klein has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Takeda. Dr. Klein has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sangamo Therapeutics . Dr. Klein has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Faze Medicine .
John R. Mills, MD, PhD (Mayo Clinic) The institution of Dr. Mills has received research support from Werfen Diagnostics. Dr. Mills has received intellectual property interests from a discovery or technology relating to health care.
Divyanshu Dubey, MD, FAAN (Mayo Clinic) The institution of Dr. Dubey has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Argenx. The institution of Dr. Dubey has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Arialys. The institution of Dr. Dubey has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UCB . Dr. Dubey has received research support from Department of Defense . Dr. Dubey has received research support from Department of Defense . Dr. Dubey has received research support from UCB. Dr. Dubey has received research support from David J. Tomassoni ALS Research Grant Program . Dr. Dubey has received intellectual property interests from a discovery or technology relating to health care. Dr. Dubey has received intellectual property interests from a discovery or technology relating to health care. Dr. Dubey has received intellectual property interests from a discovery or technology relating to health care. Dr. Dubey has received intellectual property interests from a discovery or technology relating to health care.